Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3803_Библиотеки_им_академика_М_И_Перельмана
.pdf
Index
https://t.me/medicina_free
A
Abdominal aortic aneurysms (AAA), 309
Absolute claudication distance
(ACD), 62
Acute occlusion, 85, 86
Acute procedural results, 320, 321, 323
Adventitial tears, 101
Algorithm, 322
Angiographic dissections, 101,
104, 105
Angioplasty, 124, 125
AngioSculpt balloon, 200, 201
Antiproliferative therapies, 322
Aortoiliac, 297
Atherectomy, 126, 284, 295, 299
Atherosclerosis, 18, 19
pathogenesis, 19–24, 26, 27
peripheral artery disease, 33, 34
propagation, 28–30, 32, 33
B
Balloon angioplasty, 210, 213, 217, 284
Barotrauma, 82, 83
Below-the-knee (BTK) chronic total
occlusions, 146, 266–268
Blood vessel wall structure, 81
angiography, 87
DiSForM, 90, 91
intravascular ultrasound, 88–90
uncontrolled dissection, 84
vascular remodeling, 83
C
Calcication, 137, 140
Calcium, 113
Carotid artery stenting (CAS), 144
Chimney endovascular repair of aortic
aneurysm, 310
Cholesterol, 19
Cholesteryl ester transfer protein (CETP), 27
Chronic kidney disease (CKD), 82
Chronic-limb threatening ischemia
(CLTI), 319
Chronic total occlusions (CTO), 109, 196,
218, 275
Claudication, 11, 61
Clinically driven target lesion
revascularization (CD-TLR), 213
Critical limb ischemia (CLI), 271
Critical limb threatening ischemia (CLTI),
226, 281, 282
diagnosis, 282
endovascular versus Surgical rst, 288, 289
medical management, 282, 283
revascularization, 283–288
surgical approach, 288
CTO crossing device (CCD), 259
Cutting balloons (CB), 104
D
Damage-associated molecular patterns
(DAMPs), 31
Deep injury, 102
© The Editor(s) (if applicable) and The Author(s), under exclusive license to
Springer Nature Switzerland AG 2022
N. W. Shammas (ed.), Peripheral Arterial Interventions, Contemporary
Cardiology, https://doi.org/10.1007/978-3-031-09741-6
329
330
https://t.me/medicina_free
Index
Deep vein arterialization (DVA), 289, 290
Diabetes, 54
Diffuse intimal thickening (DIT), 20
Directional atherectomy, 115, 116
DiSForM, 90
Dissection repair, 97, 105
Dissections, 209, 210
Distal embolization, 295, 305, 306
clinical relevance, 299, 300
endovascular procedurs, 295, 297
incidence, 297–299
indications, 301
SpiderFX device, 302
technique, 304
Drug coated balloons (DCBs), 112, 117, 123,
143, 209, 218
combination therapies, 231–233
drug coated balloons, 237
future innovations, 233, 234
long lesions, 231
mortality, 234–236
native femoropopliteal lesions, 222, 225
technical and pharmacologic
considerations, 219–221
Drug eluting stents (DES), 112
Duplex ultrasound (DUS), 257
E
Efferocytosis, 30, 31
Endothelial dysfunction, 19
Endovascular aneurysm repair (EVAR), 137
Endovascular bypass technology, 290
Endovascular repair of aortic aneurysm
(EVAR), 310
indications, 310
intra-operative, 312
operative technique, 315
post-operative surveillance, 316
pre-operative assessment, 312
Endovascular revascularization, 285
Endurance shuttle walk test (ESWT), 62
Fenestrated endovascular repair, 310
FLEX Vessel Prep (FLEX VP) micro-
incisions, 132
Focal force balloons, 196
G
G protein coupled receptors (GPCR), 17
Guideline-directed medical therapy
(GDMT), 272
H
Home based exercise (HE), 62, 64
Hyperlipidemia, 53
Hypertension, 53
I
iDissection, 98, 101
Inammation, 55
In-stent restenosis (ISR), 229
Intravascular lithotripsy (IVL), 126, 138, 276
device specics, 138, 139
drug coated balloons, 143
indications, 144–146
large bore vascular access, 143
peripheral artery disease, 140, 141
technical features, 139
Intravascular ultrasound (IVUS), 89, 100, 110,
124, 275
L
Laser atherectomy, 112, 113
Low- and middle-income countries (LMIC), 3
M
Major adverse limb events (MALE), 213
MER proto-oncogene tyrosine kinase
(MERTK), 30
Minimal luminal area (MLA), 97
F
Femoropopliteal chronic total
occlusions, 263–266
general principles, 254, 255
hybrid approaches, 261, 263
imaging, 257, 258
intraluminal, 259
procedure planning, 255, 256
subintimal, 259
treatment, 259
N
National Heart, Lung, and Blood Institute
(NHLBI) classication, 97, 98
N–ethylmaleimide sensitive factor (NSF), 23
Non modiable risk factors, PAD
age, 50
ethnicity, 51
family history, 50
hypertension, 53
Index
https://t.me/medicina_free
331
inammation, 55, 56
obesity, 55
renal dysfunction, 51
tobacco use, 52
O
Obesity, 55
Optical coherence tomography (OCT), 105,
124, 130
Optimal technique, 142
Orbital atherectomy (OA), 113
Oxidation, 23, 24
P
Paclitaxel, 219
Pain-free walking distance (PFWD), 64
Peak walking distance (PWD), 62
Peak walking time (PWT), 62
Percutaneous coronary interventions
(PCIs), 217
Percutaneous transluminal angioplasty (PTA),
82, 125, 140, 195, 245
atherectomy, 126
balloon angioplasty, 196
chocolate PTA balloon, 198–200
clinical benet, 124, 125
FLEX Vessel Prep system, 126, 127,
204, 205
intravascular lithotripsy, 126
peripheral cutting balloon, 197, 198
shockwave intravascular lithotripsy, 203
specialty angioplasty balloons, 125
VascuTrack, 201
Perioperative death (POD), 213
Peripheral artery disease (PAD), 1, 2, 49, 61,
123, 271, 319
arterial structure, 14–16
clinical presentation, 271, 272
detection, 8–12
diabetes, 54
endothelium, 16–18
endovascular therapy, 274–276
epidemiology and risk factors, 3–6
ethnicity, 51
evaluation, 272
family history, 50
Fontaine classication, 3
hyperlipidemia, 53
inammation, 56
ischemia induced changes, 34–37
modiable risk factors, 51, 52
non modiable risk factors, 50
obesity, 55
renal dysfunction, 51
revascularization, 274
rheology, 13
Rutherford classication, 3
tobacco use, 52
treatment, 272, 273
vascular anatomy, 12
Peripheral vascular interventions (PVI), 195
Plain balloon angioplasty (POBA), 212
Plaque modication, 123, 125, 204
Platelet-derived growth factor (PDGF), 26
Precise imaging, 98
R
Remodeling, 83
Restenosis, 86, 218
Retrograde, 260
Revascularization, 273
Rho-associated protein kinase (ROCK), 17
Rotational atherectomy, 114, 115
S
Shear stress, 210
Shockwave intravascular lithotripsy
(IVL), 202
Specialty angioplasty balloons, 125
Stents, 286
Stepped-care model (SCM), 65
Structured exercise, 65
Subintimal tracking and reentry (STAR), 261
Supercial femoral artery (SFA), 8, 124,
210, 245
challenge, 245, 246
drug-eluting, 250
rst-generation stents, 248
initial treatment approaches, 246, 247
newer-generation stents, 248, 249
nitinol-based self-expanding stents, 247
stent-grafting, 249
Supervised exercise (SE), 62, 63
Surgical bypass, 281, 285
T
Tack Optimized Balloon Angioplasty III
(TOBA III), 212
Target lesion revascularization (TLR), 112,
113, 124, 140, 143
Thoracic endovascular aneurysm repair
(TEVAR), 137
Thrombosis, 34, 35
332
https://t.me/medicina_free
Index
Tobacco use, 52
Toll-like receptors (TLRs), 24
Transcatheter aortic valve replacement
(TAVR), 137
V
Vascular Quality of Life Assessment
(VascuQOL), 62
Vessel prepping (VP), 109, 322, 323
directional atherectomy, 116
laser atherectomy, 112, 113
orbital atherectomy, 113, 114
rotational atherectomy, 114, 115
W
Walking impairment questionnaire
(WIQ), 62, 64
X
Xenon and chloride (XeCl), 112
Соседние файлы в папке Библиотека им академика М.И. Перельмана